BIANCO, ROBERTO

BIANCO, ROBERTO  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 193 (tempo di esecuzione: 0.034 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
VEGF Receptor 1 contributes to resistance to anti-EGFR drugs in human cancer cells. 1.1 Articolo in rivista 2008 Bianco, Roberto; Rosa, R; Damiano, V; Daniele, G; Gelardi, T; Garofalo, S; Tarallo, V; De Falco, S; Melisi, D; Benelli, R; Albini, A; Ryan, A; Ciardiello, F; Tortora, Giampaolo
Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. 1.1 Articolo in rivista 2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumors sensitive and resistant to anti-EGFR drugs 1.1 Articolo in rivista 2008 Bianco, Roberto; Garofalo, S; Rosa, R; Damiano, V; Gelardi, T; Daniele, G; Ciardiello, F; Tortora, Giampaolo
Oral antisense targeting protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis and growth factors production. 1.1 Articolo in rivista 2000 Tortora, Giampaolo; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) 1.5 Abstract in rivista 2012 De Stefano, A; Malapelle, Umberto; Carlomagno, Chiara; Bianco, Roberto; Marciano, Roberta; Cimminiello, C; Colantuoni, M; DE PLACIDO, Sabino; Troncone, Giancarlo
ANTITUMOR ACTIVITY OF ZD6474, A VEGFR-2 AND EGFR SMALL MOLECULE TYROSINE KINASE INHIBITOR, IN COMBINATION WITH SC-236, A CYCLOOXYGENASE-2 INHIBITOR. 1.1 Articolo in rivista 2005 Tuccillo, C; Romano, M; Troiani, T; Martinelli, E; Morgillo, F; DE VITA, F; Bianco, Roberto; Fontanini, G; Bianco, Ar; Tortora, Giampaolo; AND CIARDIELLO, F.
Fine needle aspiration cytology of a cutaneous metastasis from an extraadrenal paraganglioma: a case report. 1.1 Articolo in rivista 2010 Cozzolino, I.; Bianco, Roberto; Vigliar, E.; Vetrani, Antonio; Troncone, Giancarlo; Zeppa, P.
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. 1.1 Articolo in rivista 2004 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits. 1.1 Articolo in rivista 1996 Tagliaferri, P.; Tortora, Giampaolo; Guarrasi, R.; Damiano, Vincenzo; Ruggiero, A.; Morelli, D.; Caraglia, M.; Bianco, Roberto; di Isernia, G.; Pepe, Stefano; Arteaga, C. L.; Langton Webster, B. C.; Bianco, A. R.; Ciardiello, F.
Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. 1.1 Articolo in rivista 2001 Tortora, G; Caputo, R; Damiano, V; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells. 1.1 Articolo in rivista 2000 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Caputo, R; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Mendelsohn, J; Tortora, Giampaolo
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 1.1 Articolo in rivista 2002 Bianco, C; Tortora, Giampaolo; Bianco, Roberto; Caputo, R; Veneziani, BIANCA MARIA; Caputo, R; Damiano, Vincenzo; Troiani, T; Fontanini, G; Raben, D; Pepe, Stefano; Bianco, Ar
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part 1.5 Abstract in rivista 2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
Paraneoplastic sensitive neuropathy associated with anti-hu antibodies in a neuroendocrine tumor of duodenum: a case report. 1.1 Articolo in rivista 2010 Nappi, Lucia; Formisano, Luigi; Damiano, Vincenzo; Matano, Elide; Bianco, Roberto; Tortora, Giampaolo
The mechanisms of resistance to EGFR inhibitors. 1.1 Articolo in rivista 2007 Bianco, Roberto; Gelardi, Teresa; Damiano, Vincenzo; Tortora, Giampaolo
Rapporto medico paziente e consenso informato 2.1 Contributo in volume (Capitolo o Saggio) 2004 Marinelli, Alfredo; Bianco, Roberto
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models 1.5 Abstract in rivista 2012 Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino
SPHINGOSINE KINASE 1 (SPHK1) CONTRIBUTES TO RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS IN COLORECTAL CANCER MODELS 1.5 Abstract in rivista 2011 Nappi, L.; Rosa, R.; Damiano, V.; Formisano, L.; Gelardi, T.; D’Amato, C.; Marciano, R.; De Maio, A. P.; Ferrara, R.; Tortora, G.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
COMBINED TARGETING OF EGFR AND MDM2 BY GEFITINIB AND ANTISENSE MDM2 COOPERATIVELY INHIBIT HORMONE-INDEPENDENT PROSTATE CANCER. 1.1 Articolo in rivista 2004 Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; DE PLACIDO, Sabino; Ficorella, C; Agrawal, S; Bianco, Ar; Ciardiello, F; G., Tortora
Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model. 1.1 Articolo in rivista 2004 Ritter, Ca; Bianco, Roberto; Dugger, T; Forbes, J; Qu, S; Rinehart, C; King, W; Arteaga, Cl